HC2 Holdings, Inc. (“HC2”) (NYSE:HCHC), a diversified holding company, announced today that BeneVir Biopharm, Inc. (“BeneVir”), a privately-held biotechnology company developing oncolytic immunotherapies for the treatment of cancer, has entered into a definitive agreement to be acquired by Janssen Biotech, Inc. (“Janssen”).
When: Thursday, May 17, 20184:00 – 7:00 PM EST
Where: University of Maryland BioPark, 801 West Baltimore Street, Baltimore, MD 21201
Join the fourth in the TEDCO funded Anchor Ventures events series for an important discussion about Talent. Our expert panel will discuss how to draw the right candidates to your company, the role personnel plays in the investment process, opportunities for enhancing your existing team, and the regional supply of entrepreneurial talent.
The National Institute of Standards and Technology is looking for the public’s help in refreshing how it uses research and development funds to help bring new products to market.
The digital health rocket seems to have gotten supercharged lately, at least when it comes to fundraising. Depending on who you ask, either $1.62 billion (Rock Health’s count) or $2.5 billion (Mercom) or $2.8 billion (Startup Health’s count) was plowed into digital health companies in just the first three months of 2018. By any measure Q1 2018 was the most significant quarter yet for digital health funding. This headline has been everywhere. Digital health: to infinity and beyond! But what is the significance of this? Should investors and customers of these companies be excited or worried? It’s a little hard to tell.
One of the enduring mysteries of medicine is how individual genes, environment and lifestyle may combine to spark sickness or protect us from it. Unraveling this puzzle remains essential for scientists hoping to achieve the elusive goal of offering tailored treatments or personalized prevention plans.
Highmark Health announced today that through its VITAL Innovation Program, a test-and-learn platform, it will be evaluating WellDoc’s® BlueStar® mobile app, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes.
You’ve heard the word “blockchain” many times now, but probably not quite as many as you’ve heard the word “bitcoin.” Yet you surely have a sense that the referents of those two words have a connection, and even if you haven’t yet been interested in either, you may well know that blockchain, a technology, makes Bitcoin, a currency, possible in the first place. Their sheer novelty has already given rise to a mini-industry of explainer videos, more of them dealing directly with bitcoin than blockchain, but in time the latter could potentially overtake the former in importance, to the degree that it becomes as vital to society as the protocols that undergird the internet itself.
Scott Gottlieb, commissioner of the Food and Drug Administration, has introduced information technology initiatives under the agency’s data science incubator program during the Health Datapalooza conference in Washington, D.C., MedCityNews reported Thursday.
It’s baaaaack, that reputation-shredding, stock-moving fight to the death over key CRISPR patents. On Monday morning in Washington, D.C., the U.S. Court of Appeals for the Federal Circuit will hear oral arguments in University of California v. Broad Institute. Questions?
The Baltimore Business Journal recognized Christy Wyskiel for her ongoing efforts to perfect the “magic formula” that will further catalyze the commercialization of life-changing research and technologies emerging from labs and dorms across Johns Hopkins.
